Advanced therapy of inflammatory bowel disease . Volume 1 IBD and ulcerative colitics / / Theodore M. Bayless, Stephen B. Hanauer ; editor, Linda Mehta ; cover designer, Mary McKeon

• Record Nr.: UNINA9910827691903321
• Autore: Bayless Theodore M. <1931->
• Pubbl/distr/stampa: Shelton, Connecticut : , : People's Medical Publishing House, , 2011; ©2011
• ISBN: 1-60795-216-5
• Edizione: [Third edition.]
• Descrizione fisica: 1 online resource (648 p.)
• Disciplina: 616.3/44
• Soggetti: Inflammatory bowel diseases
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index at the end of each chapters.
• Nota di contenuto: ""Advanced Therapy of IBD: Ulcerative Colitis (Volume 1) ""; ""Contents ""; ""Contributors ""; ""Preface ""; ""Acknowledgments ""; ""Tribute ""; ""Part I: Introduction ""; ""1: Expectations for the Patient with Ulcerative Colitis ""; ""2: Expectations for the Patient with Crohn's Disease ""; ""3: Living with Ulcerative Colitis ""; ""4: Living with Crohn's Disease ""; ""5: Interactions among the Pediatric Patient, His or Her Family, and the Doctor ""; ""6: Dealing with Teens with IBD ""; ""7: Psychosocial Concomitants of Pediatric IBD ""; ""8: Recognizing and Managing Patients Concerns ""; ""9: Benefits of Enhancing the Patient-Medical Professional Interface """"Part II: Etiology and Pathophysiology of IBD ""; ""10: IBD Pathogenesis: Current Concepts ""; ""11: IBD Genetics: Potential Clinical Relevance ""; ""12: Effect of Age of Onset on IBD Phenotypes and Genotypes ""; ""13: Environmental Influences in IBD ""; ""14: Biological Therapy in IBD ""; ""15: Addressable Pathophysiologic Alterations in the IBD Patient ""; ""16: Molecular Mechanisms of Colitis-Induced Cancer ""; ""Part III: Diagnostic/Prognostic Methodology ""; ""17: Clinical Subtypes in IBD ""; ""18: Computer Database for Patients with IBD """"19: Clinical Measures of Disease Activity ""; ""20: Useful Biological Markers as Activity Indices ""; ""21: The Role of Genetics and Serology in Diagnosing and Predicting ; the Natural History of IBD ""; ""22: Pediatric IBD: Presentations and Diagnosis, Including Serologies ""; ""23: Clinical Utility of Quallity of Life Measurements ""; ""24: Endoscopy in IBD ""; ""25: Magnifying Colonoscopy in IBD Patients ""; ""26: Endoscopic Biopsies ""; ""27: Crohn's Disease: CT Scanning in Clinical Decision Making ""; ""28: CT Enterography and Other Small Bowel Imaging """"29: Imaging IBD with FDG PET and PET/CT ""; ""30: Video Capsule Endoscopy and IBD ""; ""31: Transabdominal Bowel Sonography in Clinical Decision Making ""; ""32: Imaging Options in Perianal Crohn's Disease ""; ""Part IV: Aggravating Factors in IBD ""; ""33: IBD and Stress ""; ""34: ""Refractory"" IBD - A Misnomer? ""; ""35: Infectious Agents as Aggravating Factors in IBD ""; ""36: Viral Infections in IBD ""; ""37: Clostridium difficile and IBD ""; ""38: Nonsteroidal Anti-Inflammatory Drugs and IBD ""; ""39: Smoking and Crohn's Disease ""; ""40: Reducing Dietary Symptoms in Irritable Bowel Syndrome and IBD """"41: Coexisting Irritable Bowel Syndrome and IBD ""; ""42: Managing Irritable Bowel Syndrome and IBD in the Same Individual ""; ""43: Adverse Influences of Pregnancy on IBD ""; ""Part V: Medical Therapy of IBD ""; ""44: Pharmacogenomics in IBD ""; ""45: The Placebo Response in IBD ""; ""46: Adherence Issues in the Management of IBD ""; ""47: Emerging Therapeutic Strategies for the Treatment of IBD: Mechanisms & Challenges ""; ""48: The Luminal Contents in IBD: What Clinicians Should Know About the Microbiota and its Manipulation ""